Harwood Feffer LLP is investigating potential claims against the board of directors of Pharmacyclics, Inc. (NASDAQ:PCYC) concerning the proposed acquisition of the Company by AbbVie Inc. (“AbbVie”). On Thursday shares of Pharmacyclics Inc. (NASDAQ:PCYC) closed at $254.22. Company’s sales growth for last 5 years was 139.30% and EPS growth for next 5 years is recorded as 0.16%.
Zacks lowered shares of Regado Biosciences Inc (NASDAQ:RGDO) from an outperform rating to a neutral rating in a research report released on Monday morning. Zacks currently has $1.40 price objective on the stock. Regado Biosciences, Inc. (NASDAQ:RGDO) in last trading activity advanced 1.53% to close at $1.33. Company weekly performance is 9.02% while its quarterly performance stands at 58.33%. Regado Biosciences, Inc. (NASDAQ:RGDO) is -90.57% away from its 52 week high.
On February 26, Media General, Inc. (NYSE:MEG) reported results for its fourth quarter and full year ended December 31, 2014. The Company completed its merger with LIN Media on December 19, 2014. As a result, its fourth quarter and full year 2014 GAAP financial results reflect the operating results of the television stations owned or operated by LIN Media, and its digital operations only for the period from December 19, 2014 through December 31, 2014. On last trading day Media General, Inc. (NYSE:MEG) advanced 1.21% to close at $15.07. Its volatility for the week is 4.37% while volatility for the month is 3.66%. MEG’s sales growth for past 5 years was -19.50% and its EPS growth for past 5 years was 14.90%. Media General, Inc. (NYSE:MEG) monthly performance is 1.14%.
MFA Financial, Inc. (NYSE:MFA) announced that in accordance with the terms of its 7.50% Series B Cumulative Redeemable Preferred Stock, the Board of Directors has declared a preferred stock dividend of $0.46875 per share for the quarter ending March 31, 2015. This dividend is payable on March 31, 2015, to preferred stockholders. MFA Financial, Inc. (NYSE:MFA) has 0.60% insider ownership while its institutional ownership stands at 84.10%. In last trading activity company’s stock closed at $7.94.
Petroleo Brasileiro SA (ADR) (NYSE:PBR) is on track to quantify a graft-related writedown needed to release audited financial results and restore investor confidence, according to the most recent appointee to the offshore producer’s board. On last trading day Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) moved down -1.62% to close at $6.08. Its volatility for the week is 3.50% while volatility for the month is 4.56%. PBR’s sales growth for past 5 years was 3.60% and its EPS growth for past 5 years was -17.00%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) monthly performance is -16.60%.